Ethyl 5-chloro-2-indolecarboxylate is a indole-based derivative that typically used as pharmaceutical intermediate in the preparation of a novel fusion protein inhibitor in clinical trials for the treatment of respiratory syncytial virus (RSV).
A human challenge model for respiratory syncytial virus kinetics, the pharmacological effect of a novel fusion inhibitor, and the modelling of symptoms scores. 
Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor. 
 J.Korell, et al, Eur. J. Pharm. Sci., 2017, 109S, pp S154-S160.
 D.Roymans, et al, Nat. Commun., 2017, 8(1), pp 167-181.
Not classified as hazardous substance or mixture
NONH for all modes of transport
1. Product Specification
2. Safety Data Sheet
Please inquire for pricing and availability of this product by writing email email@example.com.